Primary oligoarthritis in a parent of a child with meningococcal group B sepsis and meningitis

Netherlands Journal of Medicine

Volumn 52, Issue 5, 1998, Pages 193-196

  Bongers, Vivian ^a   Blaauw, Angelina A M ^a   Bijlsma, Johannes W J ^a   Hoepelman, Andy I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bacterial arthritis; Meningitis; Neisseria meningitidis

Indexed keywords

ADULT; ARTICLE; BACTERIAL ARTHRITIS; BACTERIUM CULTURE; CASE REPORT; CLINICAL EXAMINATION; EPIDEMIC MENINGITIS; FEMALE; FEVER; HUMAN; NEISSERIA MENINGITIDIS; PETECHIA; SEPSIS;

ANTIBIOTICS, ANTITUBERCULAR; ARTHRITIS, INFECTIOUS; CEFTRIAXONE; CEPHALOSPORINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; RIFAMPIN; SEPSIS;

EID: 0032078456     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(98)00029-1     Document Type: Article

References (14)

1. [1] Schaad VB. Arthritis in disease due to Neisseria meningitidis. Rev Infect Dis 1980;2:880-887.
2. [2] Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Parley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med 1995;123:937-940.
3. [3] Scholten RJPM, Bijlmer HA, Poolman B, et al. Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis 1993;16:237-246.
4. [4] Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging threat. J Am Med Assoc 1995;273:383-389.
5. [5] Hubert B, Caugant DA. Recent changes in meningococcal disease in Europe. Eurosurveillance 1997;2:69-71.
6. [6] Ellison RT, Kohler PF, Curd JG, Judson FN, Reller LB. Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease. N Engl J Med 1983;308:913-916.
7. [7] Kruijtzer CMF, Buiting AGM, Graafsma SJ. Chronic meningococcaemia: a case report. Neth J Med 1997;50:102-104.
8. [8] Whittle HC, Abdullahi MT, Fakunle FA, et al. Allergic complications of meningococcal disease: I. Clinical aspects. Br Med J 1973;2:733-737.
9. [9] Tappero JW, Reporter R, Wenger JD, et al. Meningococcal disease in Los Angeles county, California, and among men in the county jails. N Engl J Med 1996;335:833-840.
10. [10] Artenstein MS, Lamson Th, Evans JR. Attempted prophylaxis against meningococcal infections using intramuscular penicillin. Milit Med 1967;132:1009-1011.
11. [11] Schwartz B. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections. Rev Inf Dis 1991;13(Suppl 2):S170-S173.
12. [12] Cooper ER, Ellison RT III, Smith GS, et al. Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin. J Pediatr 1986;108:93-96.
13. [13] Kristiansen BE, Knapskog AB. Secondary prevention of meningococcal disease. Br Med J 1996;312:591-592.
14. [14] Joint Formulatory Committee 1994-1995. British National Formulatory. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1995.